Evidence map›Paper›PMID 29790874›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Point-of-care whole-exome sequencing of idiopathic male infertility.

Khalid A Fakhro, Haitham Elbardisi, Mohamed Arafa, Amal Robay, Juan L Rodriguez-Flores, Alya Al-Shakaki, Najeeb Syed, Jason G Mezey, Charbel Abi Khalil, Joel A Malek and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Khalid A FakhroTranslational Medicine, Sidra Medical and Research Center, Doha, Qatar.
Haitham ElbardisiDepartment of Urology, Hamada Medical Corporation, Doha, Qatar.
Mohamed ArafaDepartment of Urology, Hamada Medical Corporation, Doha, Qatar.
Amal RobayDepartment of Genetic Medicine, Weill Cornell Medical College-Qatar, Doha, Qatar.
Juan L Rodriguez-FloresDepartment of Genetic Medicine, Weill Cornell Medical College, New York, New York, USA.
Alya Al-Shakaki
Najeeb Syed
Jason G MezeyDepartment of Genetic Medicine, Weill Cornell Medical College, New York, New York, USA.
Charbel Abi Khalil
Joel A Malek
Abdulla Al-Ansari
Sami Al Said
Ronald G CrystalDepartment of Genetic Medicine, Weill Cornell Medical College, New York, New York, USA. geneticmedicine@med.cornell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNonobstructive azoospermia (NOA) affects 1% of the male population; however, despite state-of-the-art clinical assessment, for most patients the cause is unknown. We capitalized on an analysis of multiplex families in the Middle East to identify highly penetrant genetic causes.

methodsWe used whole-exome sequencing (WES) in 8 consanguineous families and combined newly discovered genes with previously reported ones to create a NOA gene panel, which was used to identify additional variants in 75 unrelated idiopathic NOA subjects and 74 fertile controls.

resultsIn five of eight families, we identified rare deleterious recessive variants in CCDC155, NANOS2, SPO11, TEX14, and WNK3 segregating with disease. These genes, which are novel to human NOA, have remarkable testis-specific expression, and murine functional evidence supports roles for them in spermatogenesis. Among 75 unrelated NOA subjects, we identified 4 (~5.3%) with additional recessive variants in these newly discovered genes and 6 with deleterious variants in previously reported NOA genes, yielding an overall genetic etiology for 13.3% subjects versus 0 fertile controls (p = 0.001).

conclusionNOA affects millions of men, many of whom remain idiopathic despite extensive laboratory evaluation. The genetic etiology for a substantial fraction of these patients (>50% familial and >10% sporadic) may be discovered by WES at the point of care.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdultAzoospermiaCell Cycle ProteinsConsanguinityEndodeoxyribonucleasesExome SequencingHumansInfertility, MaleMaleMeiotic Recombination Protein SPO11Middle EastMutationNuclear ProteinsPedigreeCell Cycle ProteinsEndodeoxyribonucleasesKASH5 protein, humanMeiotic Recombination Protein SPO11NANOS2 protein, humanNuclear ProteinsProtein Serine-Threonine KinasesRNA-Binding ProteinsTEX14 protein, humanTranscription FactorsWNK3 protein, humandisease geneticsmale infertilitynonobstructive azoospermiaspermatogenic failurewhole-exome sequencing

Identifiers

PMID29790874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.